跳至主要内容
临床试验/ISRCTN16086655
ISRCTN16086655进行中(未招募)1 期

Inhaled lipopolysaccharide challenge as a human model to investigate potential therapies in Acute Respiratory Distress Syndrome

Belfast Health and Social Care Trust0 个研究点目标入组 30 人开始时间: 2024年4月26日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Healthy non-smoking adults aged 18-45 years old

排除标准

  • 1. Age <18 years
  • 2. Age >45 years
  • 3. BMI >30 kg/m2
  • 4. On concomitant medications including over-the-counter medications excluding hormonal contraception and paracetamol
  • 5. Previous adverse reactions to LPS, lignocaine or sedative agents
  • 6. Pregnant or breast-feeding
  • 7. Participation in a clinical trial of an investigational medicinal product within 30 days
  • 8. Consent declined
  • 9. History of asthma or other respiratory conditions
  • 10. Smoking or e-cigarette use
  • 11. Marijuana use or other inhaled products (with or without nicotine) in the last 3 months
  • 12. Alcohol abuse, as defined by the Alcohol Use Disorders Identification Test (AUDIT)
  • 13. Subjects with history of prior conventional cigarette (> 100 cigarettes lifetime and smoking within 6 months) or electronic cigarette use.
  • 14. Live vaccine with in preceeding 4 weeks
  • 15. Abnormal blood count, renal function or liver function tests identified at screening
  • 16. History of shingles
  • 17. History of Hepatitis B/C
  • 18. Allergy to Baricitinib

研究者

相似试验